Resultats globals: 1 registres trobats en 0.02 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
14 p, 383.4 KB The Use of Rifaximin in Patients With Cirrhosis / Caraceni, Paolo (University Hospital S. Orsola-Malpighi di Bologna) ; Vargas, Victor (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Solà, Elsa (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Alessandria, Carlo (University of Torino) ; de Wit, Koos (Amsterdam UMC. University Medical Center) ; Trebicka, Jonel (EF-CLIF (Barcelona)) ; Angeli, Paolo (University Hospital of Padova (Pàdua, Itàlia)) ; Mookerjee, Rajeshwar P. (University College London) ; Durand, François (Hospital Beaujon) ; Pose, Elisa (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Krag, Aleksander (University of Southern Denmark) ; Bajaj, Jasmohan S. (Virginia Commonwealth University Medical Center) ; Beuers, Ulrich (Amsterdam UMC. University Medical Center) ; Ginès, Pere (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Universitat Autònoma de Barcelona
Rifaximin is an oral nonsystemic antibiotic with minimal gastrointestinal absorption and broad-spectrum antibacterial activity covering both gram-positive and gram-negative organisms. Rifaximin is currently used worldwide in patients with cirrhosis for preventing recurrent HE because its efficacy and safety have been proven by large randomized clinical trials. [...]
2021 - 10.1002/hep.31708
Hepatology, Vol. 74 (june 2021) , p. 1660-1673  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.